Unveiling the potential of prohibitin in cancer
Open Access
- 1 December 2015
- journal article
- review article
- Published by Elsevier in Cancer Letters
- Vol. 369 (2) , 316-322
Abstract
No abstract availableKeywords
Funding Information
- Cancer Research Wales
- Cardiff University – Peking University Cancer Institute (DAD2013)
This publication has 53 references indexed in Scilit:
- Cytoprotection by the modulation of mitochondrial electron transport chain: The emerging role of mitochondrial STAT3Mitochondrion, 2012
- Stomatin-Like Protein 2 Binds Cardiolipin and Regulates Mitochondrial Biogenesis and FunctionMolecular and Cellular Biology, 2011
- The role and therapeutic potential of prohibitin in diseaseBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2011
- Estrogen-Regulated Prohibitin Is Required for Mouse Uterine Development and Adult FunctionEndocrinology, 2011
- Identification of the Cellular Prohibitin 1/Prohibitin 2 Heterodimer as an Interaction Partner of the C-Terminal Cytoplasmic Domain of the HIV-1 GlycoproteinJournal of Virology, 2010
- A Novel Androgen Receptor Splice Variant Is Up-regulated during Prostate Cancer Progression and Promotes Androgen Depletion–Resistant GrowthCancer Research, 2009
- Prohibitin and the SWI/SNF ATPase subunit BRG1 are required for effective androgen antagonist-mediated transcriptional repression of androgen receptor-regulated genesCarcinogenesis, 2008
- A Repressive Role for Prohibitin in Estrogen SignalingMolecular Endocrinology, 2008
- Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic processBMC Cancer, 2007
- MicroRNAs: small RNAs with a big role in gene regulationNature Reviews Genetics, 2004